• Bulletin of the Korean Chemical Society
• /
• 제29권12호
• /
• pp.2491-2495
• /
• 2008

• 약학회지
• /
• 제37권1호
• /
• pp.95-99
• /
• 1993

Peroxidase activity of cytochrome P-450 was examined using N, N-dimethylaniline (NDA) as a substrate and cumene hydroperoxide (CHP) as an oxidant. The initial rates of the N-demethylation for varied concentrations of NDA (0.05-0.5 mM) by P-450 at different fixed concentrations of CHP (0.02-0.2 mM) were determined. The results suggest that P-450 proceeds its peroxidative reaction by the rapid equilibrium random bi bi mechanism to form a ternary complex with substrate and oxidant as an active intermediate.

• Journal of Microbiology and Biotechnology
• /
• 제27권5호
• /
• pp.956-964
• /
• 2017

Compactin and pravastatin are competitive cholesterol biosynthesis inhibitors of 3-hydroxy-3-methylglutaryl-CoA reductase and belong to the statin drugs; however, the latter shows superior pharmacokinetic characteristics. Previously, we reported that the bacterial P450, CYP105D7, from Streptomyces avermitilis can catalyze the hydroxylation of 1-deoxypentalenic acid, diclofenac, and naringenin. Here, we demonstrate that CYP105D7 could also catalyze compactin hydroxylation in vitro. In the presence of both bacterial and cyanobacterial redox partner systems with an NADPH regeneration system, the reaction produced two hydroxylated products, including pravastatin (hydroxylated at the C6 position). The steady-state kinetic parameters were measured using the redox partners of putidaredoxin and its reductase. The $k_m$ and $k_{cat}$ values for compactin were $39.1{\pm}8.8{\mu}M$ and $1.12{\pm}0.09min^{-1}$, respectively. The $k_{cat}/K_m$ value for compactin ($0.029min^{-1}{\cdot}{\mu}M^{-1}$) was lower than that for diclofenac ($0.114min^{-1}{\cdot}{\mu}M^{-1}$). Spectroscopic analysis showed that CYP105D7 binds to compactin with a $K_d$ value of $17.5{\pm}3.6{\mu}M$. Molecular docking analysis was performed to build a possible binding model of compactin. Comparisons of different substrates with CYP105D7 were conclusively illustrated for the first time.

• Toxicological Research
• /
• 제15권1호
• /
• pp.95-101
• /
• 1999

Cytochrome P450 (CYP) 3A4 metabolizes aflatoxin B1 (AFB1) to AFB1-exo-8,9-epoxide (8,9-epoxidation) and aflatoxin Q1 (AFQ1; 3$\alpha$-hydroxylation) simultaneously. We investigated whether each metabolite was formed via its own binding site of CAP3A4 active site. Kinetics of the formation of the two metabolites were sigmoidal and consistent with the kinetics of substrate activation. The HIll model predicted that two substrate binding wites are involved in the oxidationof AFB1 by CYP3A4. Dehydronifedipine, a metabolite of nifedipine generated by CYP3A4, inhibited the formation of AFQ1 without any inhibition in the formation of AFB1-exo-8,9-epoxidation. Dehydronifedipine was found to act as a reversible competitive inhibitor against 3$\alpha$-hydroxylation of AFB1. Vmax and S0.5 of the 8,9-epoxidation were not changed in the presence of 0, 50, or 100 $\mu\textrm{M}$ dehydronifedipine. S0.5 of 3$\alpha$-hydroxylation was increased from 58$\pm$4 $\mu\textrm{M}$ to 111$\pm$8 $\mu\textrm{M}$ in the presence of 100 $\mu\textrm{M}$ nifedipine whereas Vmax was not changed. These results suggest that there exist two independent binding sites in the active site of CAP3A4 . One binding site is responsible for AFB1-exo-8,9-epoxidation and the other is involved in 3$\alpha$-hydroxylation of AFB1. Dehydronifedipine might selectively bind to the site which is responsible for the formation of AFQ1 in the active site of CYP3A4.

• Biomolecules & Therapeutics
• /
• 제21권6호
• /
• pp.487-492
• /
• 2013

Cytochrome P450 4A11 (CYP4A11) is a fatty acid hydroxylase enzyme expressed in human liver. It catalyzes not only the hydroxylation of saturated and unsaturated fatty acids, but the conversion of arachidonic acid to 20-hydroxyeicosatetraenoic acid (20-HETE), a regulator of blood pressure. In this study, we performed a directed evolution analysis of CYP4A11 using the luminogenic assay system. A random mutant library of CYP4A11, in which mutations were made throughout the entire coding region, was screened with luciferase activity to detect the demethylation of luciferin-4A (2-[6-methoxyquinolin-2-yl]-4,5-dihydrothiazole-4-carboxylic acid) of CYP4A11 mutants in Escherichia coli. Consecutive rounds of random mutagenesis and screening yielded three improved CYP4A11 mutants, CP2600 (A24T/T263A), CP2601 (T263A), and CP2616 (A24T/T263A/V430E) with ~3-fold increase in whole cells and >10-fold increase in purified proteins on the luminescence assay. However, the steady state kinetic analysis for lauric acid hydroxylation showed the significant reductions in enzymatic activities in all three mutants. A mutant, CP2600, showed a 51% decrease in catalytic efficiency ($k_{cat}/K_m$) for lauric acid hydroxylation mainly due to an increase in $K_m$. CP2601 and CP2616 showed much greater reductions (>75%) in the catalytic efficiency due to both a decrease in $k_{cat}$ and an increase in Km. These decreased catalytic activities of CP2601 and CP2616 can be partially attributed to the changes in substrate affinities. These results suggest that the enzymatic activities of CYP4A11 mutants selected from directed evolution using a luminogenic P450 substrate may not demonstrate a direct correlation with the hydroxylation activities of lauric acid.

• Korean Chemical Engineering Research
• /
• 제44권4호
• /
• pp.387-392
• /
• 2006

이온 교환법으로 (Fe, Co)/NaY, (Fe, Co)/NaBeta (Fe, Co)/HUSY 등 (Fe,Co)/zeolite 촉매를 제조하였으며, 카테콜을 합성하는 과산화수소에 의한 페놀의 수산화 반응에서 이들의 촉매 성능을 조사하였다. (Fe, Co)/NaBeta 촉매에서는 반응온도가 $70^{\circ}C$, 페놀/과산화수소(몰) 비가 3, 페놀/촉매(무게) 비가 50, 용매(물)/페놀(무게) 비가 6인 조건에서 페놀의 전환율은 22％, 수산화 반응에 대한 선택도는 77％, 카테콜에 대한 선택도는 70％, 카테콜/하이드로퀴논의 생성비는 2.5로 가장 좋은 반응 결과를 얻었다. (Fe, Co)/zeolite 촉매는 재생하여 반복 사용해도 성능이 저하되지 않았다. 반응 전후의 (Fe, Co)/zeolite 촉매를 XRD, UV-VIS DRS, XPS 등으로 조사하여, 이를 근거로 촉매 반응 결과를 해석하였다.

• 한국미생물·생명공학회지
• /
• 제38권4호
• /
• pp.475-480
• /
• 2010

Actinomycetes are Gram-positive soil bacteria and one of the most important industrial microorganisms due to superior biosynthetic capabilities of many valuable secondary metabolites as well as production of various valuable bioconversion enzymes. Among them are cytochrome P450 hydroxylase (CYP), which are hemoproteins encoded by a super family of genes, are universally distributed in most of the organisms from all biological kingdoms. Actinomycetes are a rich source of soluble CYP enzymes, which play critical roles in the bioactivation and detoxification of a wide variety of metabolite biosynthesis and xenobiotic transformation. Cyclosporin A (CyA), one of the most commonly-prescribed immunosuppressive drugs, was previously reported to be hydroxylated at the position of 4th N-methyl leucine by a rare actinomycetes called Sebekia benihana, leading to display different biological activity spectrum such as loss of immunosuppressive activities yet retaining hair growth-stimulating side effect. In order to improve this regio-selective CyA hydroxylation in S. benihana, previously-identified several secondary metabolite up-regulatory genes from Streptomyces coelicolor and S. avermitilis were heterologously overexpressed in S. benihana using an $ermE^*$ promoter-containing Streptomyces integrative expression vector. Among tested, SCO4967 encoding a conserved hypothetical protein significantly stimulated region-specific CyA hydroxylation in S. benihana, implying that some common regulatory systems functioning in both biosynthesis and bioconversion of secondary metabolite might be present in different actinomycetes species.

• Journal of Microbiology and Biotechnology
• /
• 제31권6호
• /
• pp.890-901
• /
• 2021

The 11α-hydroxylation of canrenone can be catalyzed by Aspergillus ochraceus in bioreactors, where the geometry of the impeller greatly influences the biotransformation. In this study, the effects of the blade number and impeller diameter of a Rushton turbine on the 11α-hydroxylation of canrenone were considered. The results of fermentation experiments using a 50 mm four-blade impeller showed that 3.40% and 11.43% increases in the conversion ratio were achieved by increasing the blade number and impeller diameter, respectively. However, with an impeller diameter of 60 mm, the conversion ratio with a six-blade impeller was 14.42% lower than that with a four-blade impeller. Data from cold model experiments with a large-diameter six-blade impeller indicated that the serious leakage of inclusions and a 22.08% enzyme activity retention led to a low conversion ratio. Numerical simulations suggested that there was good gas distribution and high fluid flow velocity when the fluid was stirred by large-diameter impellers, resulting in a high dissolved oxygen content and good bulk circulation, which positively affected hyphal growth and metabolism. However, a large-diameter six-blade impeller created overly high shear compared to a large-diameter four-blade impeller, thereby decreasing the conversion ratio. The average shear rates of the former and latter cases were 43.25 s^-1 and 35.31 s^-1, respectively. We therefore concluded that appropriate shear should be applied in the 11α-hydroxylation of canrenone. Overall, this study provides basic data for the scaled-up production of 11α-hydroxycanrenone.

• Applied Biological Chemistry
• /
• 제17권3호
• /
• pp.149-176
• /
• 1974

팔종(八種)의 치환(置換) diphenyl ether 제초제(除草劑)를 Rayonet 광화학(光化學) 반응기(反應器)를 사용(使用)한 모조환경조건하(模造環境條件下)에서 용액상(溶液相) 광분해(光分解)시켜 그 분해산물(分解産物)에 관(關)하여 연구(硏究)하였다. 시료(試料)로 사용(使用)된 화합물(化合物)들은 300 nm에서 광화학반응(光化學反應)을 일으키기에 충분(充分)한 energy를 흡수(吸收)하였으며 분해산물(分解産物)은 tlc, glc, ir, ms, 그리고 nmr 등(等)에 의(依)하여 확인(確認)하였다. 그 결과(結果)를 요약(要約)하면 C-6989의 용액상(溶液相) 광분해(光分解) : p-nitrophenol이 다량(多量) 생성(生成)됨을 보아 ether결합(結合)의 결렬이 주반응(主反應)이며 치환기(置換基) $NO_2{\rightarrow}NH_2$의 광화학적(光化學約) 환원반응(還元反應)과 $CF_3{\rightarrow}COOH$의 산화반응(酸化反應)도 관찰되었다. p-Nitrophenol의 수중(水中) 광분해(光分解) : quinone(0.28%), hydroquinone(0.66%) 및 p-aminophenol(0.42%)과 비교적(比較的) 소량(少量)의 미지화합물(未知化合物)이 생성(生成)됨을 확인(確認)하였고 모화합물(母化化合物)은 대부분(大部分) 작용(作用)을 받지 않은 채로 존재(存在)하였다. 이들 분해산물(分解産物)의 형성기구(形成機構)는 $n{\rightarrow}{\pi}^*$ 및 여기(勵起)를 거친 nitro-nitrite재배열(再配列) 및 자유기(自由基)에 의(依)한 수소탈취(水素脫取)를 통(通)한 광환원(光還元)으로 추측(推測)되었다. Nitrofen의 용액상(溶液相) 광분해(光分解) : n-hexane중(中)에서는 $NO_2$기(基)의 광환원(光遷元)이 주반응(主反應)이었고 수용액(水溶液) 중(中)에서는 광환원(光遷元) 및 hydroxylation이 ether결합(結合) 결렬 보다 현저하였다. hydroxide ion에 의한 친핵적(親核的) 치환(置換), hydroxyl기(基) 및 소량(少量)이긴 하지만 수소(水素)에 의한 염소(鹽素)의 치환(置換)도 다소 관찰되었다. MO-338의 용액상(溶液相) 광분해(光分解) : n-hexane용액중(中) nitro기(基)의 광환원(光遷元) 반응(反應)과 수용액중(水溶液中)에서의 광환원(光遷元) 및 hydroxylation이 주반응(主反應)이었으며 hydroxyl기(基)와 수소(水素)에 의(依)한 염소(鹽素)의 치환(置換) 및 ether결합(結合)의 결렬도 볼 수 있었다. n-Hexane과 cyclohexane중(中)에서의 MC-4379, MC-3761, MC-5127, MC-6063 및 MC-7181의 광분해(光分解) : nitro기(基)의 광환원반응(光還元反應)과 수소(水素)에 의(依)한 halogen의 치환반응(置換反應)이 주(主)로 일어났다. MC-4379의 수중(水中) 광분해(光分解) : ether결합(結合)의 결렬, hydroxyl기(基)에 의한 carboxymethyl기(基)의 치환(置換), hydroxylation, hydroxyl기(基)에 의한 nitro기(基)의 치환(置換)이 주(主)로 일어났고 광환원(光還元) 및 광염소화반응(光鹽素化反應)도 약간 일어났다. MC-3761의 수중(水中) 광분해(光分解) : ether결합(結合)의 결렬, hydroxyl기(基)에 의한 carboxymethyl기(基)의 치환(置換) 및 hydroxylation이 수반되는 광환원(光還元)이 주반응(主反應)이었다. MC-5127의 수중(水中) 광분해(光分解) : 수소(水素)에 의한 carboxyethyl기(基)의 치환(置換)이 현저 하였고 ether결합(結合)의 결렬, 광환원(光還元) 및 탈염소화반응(脫鹽素化反應)도 약간 관찰되었으며 decarboxyethylation은 decarxy-methylation보다 용이함을 볼 수 있었다. MC-6063의 수중(水中) 광분해(光分解) : ether결합(結合)의 결렬과 탈염소화반응(脫鹽素化反應)이 주(主)로 관찰되었다. MC-7181의 수중(水中) 광분해(光分解) : 수소(水素)에 의한 carboxymethyl기(基)의 치환(置換)과 monodechlorination이 현저하였고 ether결합(結合) 결렬과 hydroxylation도 약간 일어났다. 3-Carboxymethyl-4-nitrophenol의 수중(水中) 광분해(光分解) : 방향족(芳香族) ester에서 흔히 볼 수 있는 광유도(光誘導) Fries rearrangement는 이 화합물(化合物)의 carboxymethyl기(基)에서는 볼 수 없었고 $nitro{\to}nitroso$반응(反應)이 주(主)로 일어났다.

• Toxicological Research
• /
• 제11권1호
• /
• pp.23-29
• /
• 1995

Microsomes from human liver sample HL 110 oxidized aflatoxin $B_1$ $(AFB_1)$ to $AFB_1$ exo-8, 9-epoxide which was detected as a glutathione (GSH) conjugate with excess GSH S-transferase and to aflatoxin $Q_1$ ($AFB_1$; 3$\alpha$-hydroxyafiatoxin $B_1$), and testosterone to 6$\beta$-hydroxytestosterone. Anti-P450 3A4 nearly completely inhibited all of the reactions. Some fiavonoids inhibited all of the reactions. While other fiayonolds stimulated 8, 9-epoxidation and inhibited 3$\alpha$-hydroxylation. Gestodene inhibited all of the reactions when gestodene was metabolized by human liver microsomal P450 3A4 prior to adding substrate. But, ges-todene was added in the enzyme mixtures in the presence of $AFB_1$, it could not inhibit 8, 9-epoxidation of $AFB_1$. Nifedipine and troleandomycin inhibited both of the reactions of $AFB_1$ but only 3$\alpha$-hydroxylation was inhibited by the oxidation product of nifedipine. Although, troleandomycin was known as a mechanism-based inhibitor, the chemical did not show any detectable inhibitory effect on 6$\beta$-hydroxylation of testosterone. The results suggest that there are several different substrate-binding sites on P450 3A4.